{
    "pmcid": "10966652",
    "qa_pairs": {
        "What is the potential advantage of targeting an allosteric site on MPro with nanobodies like NB2B4?": [
            "It could be less susceptible to resistance compared to targeting the catalytic site",
            "It increases the enzymatic activity of MPro",
            "It allows the nanobody to bind to multiple viral proteins simultaneously",
            "It enhances the replication of SARS-CoV-2"
        ],
        "What is the primary target of the nanobody NB2B4 in the study?": [
            "An allosteric site on the SARS-CoV-2 main protease (MPro)",
            "The catalytic domain of the SARS-CoV-2 main protease (MPro)",
            "The spike protein of SARS-CoV-2",
            "The RNA polymerase of SARS-CoV-2"
        ],
        "What type of interaction does the residue R106 form with MPro residues?": [
            "Strong salt-bridging interactions",
            "Weak hydrogen bonding interactions",
            "Van der Waals interactions",
            "Covalent bonding interactions"
        ],
        "Which mutation was found to enhance the binding affinity of the nanobody to MPro?": [
            "D62R",
            "Y59G",
            "R106A",
            "L109G"
        ],
        "Which residues in the nanobody NB2B4 are identified as significant contributors to binding affinity with MPro?": [
            "Y59, R106, and L109",
            "L107 and P110",
            "H112 and T113",
            "D62 and T113"
        ]
    }
}